Guest guest Posted March 31, 2009 Report Share Posted March 31, 2009 The Liver Update The Liver Update Donate now A Newsletter from the American Liver Foundation March 31, 2009 In This Issue - Fat Storage and NAFLD - Liver Cancer Research - Liver Health Today Magazine - HCC Clinical Trial Recruiting Walk for Fun... Walk for Life! Coming up: Live Life Walk Nashville April 4, 2009 Register for Nashville Find another Walk Be a Part of the Team That Wins Every Time! Find a Challenge near you Give While You Shop, Shop While You Give Download the GiveClicks Shopping Assistant and a portion of what you spend online at thousands of major retail vendors will go to support the ALF mission. This contribution is made at no additional cost to you. Just shop online as you normally would and GiveClicks takes care of the rest! Download the GiveClicks Shopping Assistant today Find an ALF Chapter Near You Click here Difference In Fat Storage May Explain Lower Rate Of Liver Disease In African-Americans UT Southwestern Medical Center, ScienceDaily, March 27, 2009. Where different ethnic groups store fat in their bodies may account for differences in the likelihood they'll develop insulin resistance and non-alcoholic fatty liver disease, researchers at UT Southwestern Medical Center have found. Read more New Link In Liver Cancer Rockefeller University Press, ScienceDaily, March 30, 2009. Liver damage can be triggered by various insults, including hepatitis infection or alcohol-induced cirrhosis. In severe cases, this damage can lead to cancer. A new study by researchers at the National Institutes of Health and Osaka University reveals how one protein helps decide the fate of damaged livers in mice. Read more Liver Health Today Celebrates 10th Anniversary Liver Health Today (formerly Hepatitis magazine) is the nation's first and only magazine dedicated to persons living with liver disease. With so much information about liver disease available from many sources, it could be a full-time job for a patient to try to keep up with all of it. Liver Health Today is committed to making the search for information more manageable for patients, their families and their caregivers. In celebration of the magazine's 10th anniversary, Liver Health Today and the American Liver Foundation have joined forces to create a special collaborative issue coming out in April. With the most updated information about liver disease and special offers for readers, we hope you enjoy reading it as much as we did putting it together for you! As a rea der of "The Liver Update," you are entitled to receive a discount on your subscription to Liver Health Today. Just enter promo code LHALF when you subscribe online. Celsion's HEAT Study Now Enrolling Recently Diagnosed HCC Patients In Clinical Trials Celsion Corporation is an oncology drug development company which develops targeted chemotherapeutic treatments based on a unique heat-ac tivated liposomal technology. Celsion is currently enrolling patients in a global Phase III clinical trial - the HEAT Study - which is designed to demonstrate the safety and efficacy of ThermoDox® in hepatocellular carcinoma (HCC) patients. The HEAT study involves an investigational anti-cancer drug, called ThermoDox®, used in combination with an approved medical device for radiofrequency ablation (RFA) in the liver. The study will be the largest investigation of RFA in HCC and will involve approximately 600 patients in over 40 research institutions in seven countries and regions. ThermoDox is designed as a heat-activated liposomal technology that is administered intravenously. When used in combination with RFA to ablate tumors, high concentrations of doxorubicin are released directly to the tumor and the surrounding liver tissue. The primary endpoint of the trial is progression-free survival. For more information, write to mmasotti@... or call . Details on the HEAT study can be found online. Thank you for your continued support of the American Liver Foundation. For more information on liver disease or our work as an organization, please visit our Web site or contact your local ALF chapter. Give to ALF today. Forward email This email was sent to cmp12305@... by update@.... Update Profile/Email Address | Instant removal with SafeUnsubscribe™ | Privacy Policy. Email Marketing by American Liver Foundation | 75 Maiden Lane | Suite 603 | NEW YORK | NY | 10038 Need a job? Find employment help in your area. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.